anmelden
SLI
2.321,81
PKT
-15,88
PKT
-0,68
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu SLI-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 09.09.25 | Novartis Neutral | JP Morgan Chase & Co. | |
| 09.09.25 | ABB (Asea Brown Boveri) Neutral | JP Morgan Chase & Co. | |
| 09.09.25 | Swiss Re Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 09.09.25 | UBS Overweight | JP Morgan Chase & Co. | |
| 05.09.25 | Novartis Neutral | UBS AG | |
| 04.09.25 | Swiss Re Underweight | Barclays Capital | |
| 04.09.25 | Zurich Insurance Equal Weight | Barclays Capital | |
| 04.09.25 | Richemont Sector Perform | RBC Capital Markets | |
| 04.09.25 | Swiss Re Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 04.09.25 | Holcim Buy | Goldman Sachs Group Inc. | |
| 04.09.25 | Roche Buy | UBS AG | |
| 04.09.25 | Nestlé Hold | Jefferies & Company Inc. | |
| 03.09.25 | Nestlé Hold | Deutsche Bank AG | |
| 02.09.25 | Zurich Insurance Underweight | JP Morgan Chase & Co. | |
| 02.09.25 | Nestlé Market-Perform | Bernstein Research | |
| 02.09.25 | Nestlé Neutral | JP Morgan Chase & Co. | |
| 02.09.25 | ABB (Asea Brown Boveri) Sector Perform | RBC Capital Markets | |
| 02.09.25 | Nestlé Add | Baader Bank | |
| 02.09.25 | Novartis Hold | Jefferies & Company Inc. | |
| 02.09.25 | Nestlé Sector Perform | RBC Capital Markets | |
| 02.09.25 | Nestlé Neutral | UBS AG | |
| 02.09.25 | Nestlé Hold | Jefferies & Company Inc. | |
| 01.09.25 | Givaudan Halten | DZ BANK | |
| 01.09.25 | Roche Underweight | JP Morgan Chase & Co. | |
| 29.08.25 | Nestlé Hold | Jefferies & Company Inc. | |
| 29.08.25 | Novartis Neutral | UBS AG | |
| 29.08.25 | Nestlé Neutral | UBS AG | |
| 29.08.25 | Nestlé Hold | Deutsche Bank AG | |
| 29.08.25 | ABB (Asea Brown Boveri) Neutral | JP Morgan Chase & Co. | |
| 28.08.25 | Richemont Outperform | Bernstein Research | |
| 28.08.25 | Givaudan Overweight | JP Morgan Chase & Co. | |
| 28.08.25 | Givaudan Hold | Deutsche Bank AG | |
| 27.08.25 | Novartis Buy | Deutsche Bank AG | |
| 27.08.25 | Givaudan Neutral | UBS AG | |
| 27.08.25 | UBS Buy | Goldman Sachs Group Inc. | |
| 27.08.25 | Givaudan Overweight | JP Morgan Chase & Co. | |
| 27.08.25 | Givaudan Underperform | Jefferies & Company Inc. | |
| 22.08.25 | Novartis Neutral | UBS AG | |
| 21.08.25 | Richemont Sector Perform | RBC Capital Markets | |
| 21.08.25 | Richemont Outperform | Bernstein Research |
